Indian pediatrics · 2014
Clinical profile and outcome of clinical BCG disease in infants.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Indumathi C K, Kowtal Priyadarashini M, Poornima R N, Lewin Sanjiv
Аннотация
OBJECTIVE: To describe the clinical profile, immunological status and outcome of BCG disease in infants.
METHODS: All infants with a diagnosis of BCG disease in a period of 17 months were followed up.
RESULTS: Among 25 infants with BCG disease; 19 had local/regional involvement and 6 had suspected or confirmed distant/disseminated disease, Mean (range) age of presentation was 3.6 (1.5-9) months. Two of 6 infants with disseminated disease required second-line anti-tubercular treatment. One infant with confirmed disseminated disease had INFg R1 receptor deficiency. There was no mortality.
CONCLUSION: Most infants with BCG- related disease have local or regional disease.
METHODS: All infants with a diagnosis of BCG disease in a period of 17 months were followed up.
RESULTS: Among 25 infants with BCG disease; 19 had local/regional involvement and 6 had suspected or confirmed distant/disseminated disease, Mean (range) age of presentation was 3.6 (1.5-9) months. Two of 6 infants with disseminated disease required second-line anti-tubercular treatment. One infant with confirmed disseminated disease had INFg R1 receptor deficiency. There was no mortality.
CONCLUSION: Most infants with BCG- related disease have local or regional disease.